CBD might help prime cells against COVID

Synthetic cannabidiol, a non-psychoactive compound also found in the cannabis plant, appears to prime the innate immune system of cells, potentially offering protection against pathogens such as SARS-CoV-2.

Diseases, Conditions, Syndromes

T-cells: The superheroes in the battle against omicron

Omicron is spreading rapidly throughout the world, with experts claiming that 40% of the global population will be infected within the next two months. This sounds quite startling, but we still don't really know whether omicron ...


Key protein drives our immune response against viruses

Scientists have just slotted into place a big piece of the puzzle that explains how our blood cells mount their first line of defense against viruses. They hope this discovery will help them one day better control the response ...


Shedding more light on how the body controls our immune systems

The membrane attack complex (MAC) is a set of proteins typically formed on the surface of pathogen cell membranes. They punch tiny holes in an invading bacteria's membrane. The bacteria ultimately dies if enough holes are ...

Diseases, Conditions, Syndromes

Scientists identify antibodies that can neutralize omicron

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses ...

Diseases, Conditions, Syndromes

Dominant Alpha variant evolved to evade our innate immune system

The SARS-CoV-2 Alpha (B.1.1.7) variant mutated to evade our 'innate immune system', helping establish it as the world's first 'Variant of Concern', finds a new study led by researchers at UCL and the Quantitative Biosciences ...


EU agency to decide on Novavax Covid jab next week

The EU's drug regulator said on Thursday it would decide whether the Novavax coronavirus jab will become the fifth vaccine approved for the bloc at a meeting next Monday.


Cambridge needle-free coronavirus vaccine enters clinical trial

Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive ...

Medical research

Hunt for the protein TGM1 led to disease discovery

By searching for the protein TGM1 among patients with various autoimmune skin diseases, researchers have successfully identified a separate disease that can be linked to autoimmunity against TGM1. This backward method demonstrates ...

page 1 from 40